COVID-19 Switzerland
Information on the current situation, as of 20 January 2022
Overview of the epidemiological situation
Week 1 starting 10.01.2022, Switzerland and Liechtenstein
Due to delayed reporting, the difference in hospitalisations and deaths may still change significantly.
| Total until 16.01.2022 | Week 52 starting 03.01.2022 | Week 1 starting 10.01.2022 | Difference | |
|---|---|---|---|---|
| Laboratory-confirmed cases | 1 746 144 | 181 122 | 185 406 | +2,4% |
| Laboratory-confirmed cases Switzerland | 1 738 698 | 180 622 | 184 853 | +2,3% |
| Laboratory-confirmed cases Liechtenstein | 7446 | 500 | 553 | +10,6% |
| Laboratory-confirmed hospitalisations | 41 780 | 783 | 576 | −26,4% |
| Laboratory-confirmed hospitalisations Switzerland | 41 538 | 783 | 574 | −26,7% |
| Laboratory-confirmed hospitalisations Liechtenstein | 242 | 0 | 2 | - |
| Laboratory-confirmed deaths | 12 184 | 98 | 89 | −9,2% |
| Laboratory-confirmed deaths Switzerland | 12 117 | 98 | 89 | −9,2% |
| Laboratory-confirmed deaths Liechtenstein | 67 | 0 | 0 | - |
| Tests | 16 067 699 | 567 362 | 603 870 | +6,4% |
| Tests PCR tests | 11 802 046 | 457 609 | 499 799 | +9,2% |
| Tests Rapid antigen tests | 4 265 653 | 109 753 | 104 071 | −5,2% |
| Tests Share of positive PCR tests | 14,3% | 37,7% | 37,9% | +0,2pp |
| Tests Share of positive rapid antigen tests | 6,2% | 28,1% | 27,9% | −0,2pp |